Serologisches Markerprofil der progressiven systemischen Sklerodermie

  • H.-J. Lakomek
  • G. Goerz
  • H. L. Krüskemper
Conference paper

Zusammenfassung

Auf der Basis charakteristischer histopathologischer Merkmale faßte Klemperer 1941 eine Gruppe bestimmter entzündlich rheumatischer Erkrankungen als „Kollagenkrankheiten“zusammen, zu denen heute die progressiv systemische Sklerodermie (PSS), der systemische Lupus erythematodes (SLE), die Dermato-Polymyositis (DM/PM), das Sjögren-Syndrom (SS) und die rheumatoide Arthritis (RA) zählen (Klemperer et al., 1941).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Ceppelini R, Polli E, Celada F (1957) A DNA reacting factor in serum of a patient with lupus erythematosus diffusus. Proc Soc Exper Biol Med (N. Y.) 96: 572–574Google Scholar
  2. 2.
    Earnshaw WC, Rothfield N (1985) Identification of a family of human centromere proteins using autoimmune sera from patients with scleroderma. Chromosoma 91: 313–321PubMedCrossRefGoogle Scholar
  3. 3.
    Follansbee WP, Curtiss EI, Medsger TA, Steen VD, Vretsky BF, Owens GR, Rodnan GP (1984) Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. N Engl J Med 310: 142–148PubMedCrossRefGoogle Scholar
  4. 4.
    Fritzler MJ, Kinsella D, Garbutt E (1980) The CREST syndrome: A distinct serologic entity with anticentromere antibodies. Am J Med 69: 520–526PubMedCrossRefGoogle Scholar
  5. 5.
    Guldner HH, Lakomek HJ, Szostecki C, Bautz FA (1985) Autoantibody profiles in patients with SLE, scleroderma, and overlap-syndromes. Protides of the Biological Fluids 33: 287–291Google Scholar
  6. 6.
    Guldner HH, Lakomek HJ, Bautz FA (1984) Human anticentromere sera recognize a 19,5 kD non-histone chromosomal protein from HeLa-cells. Clin Exp Immunol 58: 13–20PubMedGoogle Scholar
  7. 7.
    Guldner HH, Szostecki C, Vosberg HP, Lakomek HJ, Penner E, Bautz FA (1986) Scl-70-autoantibodies from scleroderma patients recognize a 95 kDa-protein identified as DNA topoisomerase I. Chromosoma 94: 132–138PubMedCrossRefGoogle Scholar
  8. 8.
    Haynes DC, Gershwin ME (1982) The immunopathology of progressive systemic sclerosis (PSS). Sem Arthr Rheum 11: 331–351CrossRefGoogle Scholar
  9. 9.
    Hochberg MC, Boyd RE, Ahearn JM, Arnett FC, Bias WB, Provost TT, Stevens MB (1985) Systemic lupus erythematosus — a review of clinics, laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine 64: 285–295PubMedCrossRefGoogle Scholar
  10. 10.
    Kiparski A, Stechemesser E, Berg PA (1986) Autoantikörper-Profile bei Kollagenerkrankungen. Dt Med Wochenschr 111: 1234–1241CrossRefGoogle Scholar
  11. 11.
    Klemperer P, Pollak AD, Baehr G (1941) Pathology of disseminated lupus erythematosus. Arch Path (Chicago) 32: 569–631Google Scholar
  12. 12.
    Lakomek HJ (1986) Der systemische Lupus erythematodes in der Differentialdiagnostik entzündlich rheumatischer Erkrankungen. Schattauer, Stuttgart New YorkGoogle Scholar
  13. 13.
    Lakomek HJ, Guldner HH, Bautz FA, Goerz G, Kind P, Mensing H, Krüskemper HL (1986) Kernantikörper als serologische Marker der progressiv systemischen Sklerodermie (PSS). Der Hautarzt (im Druck)Google Scholar
  14. 14.
    Lerner MR, Steitz JA (1979) Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus. Proc Natl Acd Sci (USA) 76: 5495–5499CrossRefGoogle Scholar
  15. 15.
    Masi AT, Rodnan GP, Medsger TA, Altman RD, D’Angelo WA, Fries JF, LeRoy EC, Kirsner AB, McKenzie AH, McShane DJ, Myers RA, Sharp GC (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23: 581–590CrossRefGoogle Scholar
  16. 16.
    Meurer M, Scharf A, Luderschmidt C, Braun-Falco O (1985) Zentromerantikörper und Antikörper gegen Scl-70-Nucleoprotein bei progressiver systemischer Sklerodermie. Dt Med Wochenschr 110: 8–14CrossRefGoogle Scholar
  17. 17.
    Moroi Y, Peebles C, Fritzler MJ, Steigerwald J, Tan EM (1980) Autoantibody of centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci (USA) 77: 1627–1631CrossRefGoogle Scholar
  18. 18.
    Robbins WC, Holman HR, Deicher H, Kunkel HG (1957) Complement fixation with cell nuclei and DNA in lupus erythematosus. Proc Soc Exper Biol Med 96: 575–579Google Scholar
  19. 19.
    Shero JH, Bordwell B, Rothfield NF, Earnshaw WC (1986) High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients. Science 231: 737–740PubMedCrossRefGoogle Scholar
  20. 20.
    Stott DI (1985) Autoantibodies and nuclear antigens. Immunology Today 6: 314–315CrossRefGoogle Scholar
  21. 21.
    Takehara K, Moroi Y, Ishibashi Y (1985) Antinuclear antibodies in the relatives of patients with systemic sclerosis. Br J Derm 112: 23–33CrossRefGoogle Scholar
  22. 22.
    Tan EM (1982) Autoantibodies to nuclear antigens (ANA): Their immunobiology and medicine. Adv Immunol 33: 167–240PubMedCrossRefGoogle Scholar
  23. 23.
    Tan EM, Rodnan GP, Garcia I, Moroi Y, Fritzler HJ, Peebles C (1980) Diversity of antinuclear antibodies in progressive systemic sclerosis. Arthr Rheum 23: 617–625CrossRefGoogle Scholar
  24. 24.
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271–1277PubMedCrossRefGoogle Scholar
  25. 25.
    Tuffanelli DL, McKeon F, Kleinsmith DAM, Burnham TK, Kirschner M (1983) Anticentromere and anticentriole antibodies in the scleroderma spectrum. Arch Dermatol 119: 560–566PubMedCrossRefGoogle Scholar
  26. 26.
    Ze-yi Chen MD, Virella G, Tung HE, Ainsworth SK, Silver RM, An-Chuan Wang, La Via MF, Maricq HR, Dobson RL (1984) Immune Complexes and Antinuclear, Antinucleolar and Anticentromere Antibodies in Scleroderma. J Am Acad Dermatol 11: 461–467CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • H.-J. Lakomek
  • G. Goerz
  • H. L. Krüskemper

There are no affiliations available

Personalised recommendations